Abstract: The invention relates to a method and novel types of agents for modulating appetite and/or body weight in a subject. Moreover, the invention relates to a method of screening for agents which interact and modulate the activity of the receptor complex for macrophage inhibitory cytokine-1 (MIC-1).
Type:
Application
Filed:
August 18, 2008
Publication date:
November 4, 2010
Inventors:
Samuel Norbert Breit, David Alexander Brown, Herbert Herzog, Shu Lin
Abstract: Methods are provided for coating crystalline microparticles with an active agent by altering the surface properties of the microparticles in order to facilitate favorable association on the microparticle by the active agent. Type of surface properties that are altered by the disclosed methods include by electrostatic properties, hydrophobic properties and hydrogen bonding properties.
Abstract: Insl5 has been found to be orexigenic, i.e. it increases appetite. Insl5, or a derivative or fragment thereof that retains the ability to bind to the GPR100 receptor, or an Insl5 antibody, are useful in therapy, in particular to treat anorexia nervosa, bulimia, cachexia or wasting disease.
Type:
Application
Filed:
September 5, 2008
Publication date:
October 28, 2010
Applicant:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventors:
Johannes Grosse, Helen Heffron, Kate Day